Prefrontal involvement related to cognitive impairment in progressive muscular atrophy

Neurology

Volumn 83, Issue 9, 2014, Pages 818-825

  Raaphorst, Joost ^a,f   Van Tol, Marie José ^c   Groot, Paul F C ^a   Altena, Ellemarije ^e,g   Van Der Werf, Ysbrand D ^b,e   Majoie, Charles B ^a   Van Der Kooi, Anneke J ^a   Van Den Berg, Leonard H ^d   Schmand, Ben ^a   De Visser, Marianne ^a   Veltman, Dick J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BOLD SIGNAL; BRAIN SIZE; CATEGORY FLUENCY TEST; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; INFERIOR FRONTAL GYRUS; LETTER FLUENCY TEST; MALE; MENTAL TASK; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; WHITE MATTER LESION;

EID: 84921943583     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000745     Document Type: Article

References (40)

1. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. J Neurol Neurosurg Psychiatry 2012;83:102-108.
2. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005;65:1774-1777.
3. Chiò A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 2012;78:1085-1089.
4. Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 2013;12:368-380.
5. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis: A PET study. Brain 1996;119:2105-2120.
6. Abrahams S, Goldstein LH, Simmons A, et al. Word retrieval in amyotrophic lateral sclerosis: A functional magnetic resonance imaging study. Brain 2004;127:1507-1517.
7. Raaphorst J, de Visser M, Linssen WH, de Haan RJ, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis. Amyotroph Lateral Scler 2010; 11:27-37.
8. Quinn C, Elman L, McCluskey L, et al. Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS. Neurology 2012;79:583-588.
9. Abrahams S, Goldstein LH, Suckling J, et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005;252:321-331.
10. Wicks P, Abrahams S, Leigh PN, Williams T, Goldstein LH. Absence of cognitive, behavioral, or emotional dysfunction in progressive muscular atrophy. Neurology 2006;67:1718-1719.
11. Kew JJ, Brooks DJ, Passingham RE, Rothwell JC, Frackowiak RS, Leigh PN. Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: A comparative PET study. Neurology 1994;44: 1101-1110.
12. van der Graaff MM, Sage CA, Caan MW, et al. Upper and extra-motoneuron involvement in early motoneuron disease: A diffusion tensor imaging study. Brain 2011;134: 1211-1228.
13. Raaphorst J, de Visser M, van Tol MJ, et al. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy. J Neurol Neurosurg Psychiatry 2011;82:170-175.
14. Visser J, van den Berg-Vos RM, Franssen H, et al. Disease course and prognostic factors of progressive muscular atrophy. Arch Neurol 2007;64:522-528.
15. Cervenakova L, Protas II, Hirano A, et al. Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS). J Neurol Sci 2000;177:124-130.
16. Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252-1258.
17. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
18. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
19. Desmond JE, Glover GH. Estimating sample size in functional MRI (fMRI) neuroimaging studies: statistical power analyses. J Neurosci Methods 2002;118:115-128.
20. Thirion B, Pinel P, Mériaux S, Roche A, Dehaene S, Poline JB. Analysis of a large fMRI cohort: statistical and methodological issues for group analyses. Neuroimage 2007;35:105-120.
21. Cedarbaum JM, Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997;152(suppl 1): S1-S9.
22. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51:1104-1109.
23. Benton A, Hamsher K, Sivan A. Multilingual Aphasia Examination, 3rd ed. Iowa City: AJA Publishers; 1983.
24. Luteijn F, Barelds DPH. Groningen Intelligence Test 2 (git2): Manual. Amsterdam: Harcourt Test Publishers; 2004.
25. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
26. Altena E, van der Werf YD, Sanz-Arigita EJ, et al. Prefrontal hypoactivation and recovery in insomnia. Sleep 2008;31:1271-1276.
27. Schmand B, Groenink SC, van den Dungen M. Letter fluency: psychometric properties and Dutch normative data [in Dutch]. Tijdschr Gerontol Geriatr 2008;39: 64-76.
28. Van Overschelde JP, Rawson KA, Dunlosky J. Category norms: An updated and expanded version of the norms. J Mem Lang 2004;50:289-335.
29. Kew JJ, Goldstein LH, Leigh PN, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: A neuropsychological and positron emission tomography study. Brain 1993;116:1399-1423.
30. WFU PickAtlas Toolbox. Available at: http://www.ansir.wfubmc.edu. Accessed April 22, 2014.
31. Strauss E, Sherman E, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford University Press; 2006.
32. Mohammadi B, Kollewe K, Samii A, Dengler R, Münte TF. Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Hum Brain Mapp 2011;32: 750-758.
33. Lulé D, Ludolph AC, Kassubek J. MRI-based functional neuroimaging in ALS: An update. Amyotroph Lateral Scler 2009;10:258-268.
34. Rottig D, Leplow B, Eger K, Ludolph AC, Graf M, Zierz S. Only subtle cognitive deficits in non-bulbar amyotrophic lateral sclerosis patients. J Neurol 2006; 253:333-339.
35. Grossman M, Anderson C, Khan A, Avants B, Elman L, McCluskey L. Impaired action knowledge in amyotrophic lateral sclerosis. Neurology 2008;71:1396-1401.
36. Horwitz B, Amunts K, Bhattacharyya R, et al. Activation of Broca's area during the production of spoken and signed language: A combined cytoarchitectonic mapping and PET analysis. Neuropsychologia 2003;41:1868-1876.
37. Bak TH, O'Donovan DG, Xuereb JH, Boniface S, Hodges JR. Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. Brain 2001;124:103-120.
38. Rakowicz WP, Hodges JR. Dementia and aphasia in motor neuron disease: An underrecognised association? J Neurol Neurosurg Psychiatry 1998;65:881-889.
39. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263-1269.
40. Chiò A, Vignola A, Mastro E, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol 2010;17:1298-1303.